Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

HKG/2630 stock hub

HKG/2630 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2630is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

13B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2630

In the news

Latest news · HKG/2630

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/En/a

P25 10.7P50 17.9P75 38.5

ROE-124

P25 -14.7P50 2P75 9.4

ROIC-25.5

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2630 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

120

Groups with data

Currency

CNY

Showing 120 of 120 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Enterprise value	HKD 13.1B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-05-10
Market cap	HKD 13B
Price	HKD 77.3
Price currency	HKD
Sector	Healthcare
Sic	2834
Symbol	hkg/2630
Website	https://www.vigonvita.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.06%
EV Earnings	-33.06x
EV/Sales	115.19x
P/B ratio	26.72x
P/S ratio	114.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	79.02%
Gross Profit	HKD 89.8M
Net Income	HKD -395.8M
Pretax Margin	-349.58%
ROA	-20.73
ROCE	-43.69
ROE	-124
ROIC	-25.49

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	762.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.1
Assets	HKD 1.4B
Cash	HKD 576.1M
Current Assets	HKD 646.4M
Current Liabilities	HKD 603.7M
Debt	HKD 719.5M
Debt Equity	HKD 1.48
Equity	HKD 484.9M
Interest Coverage	-25.02
Liabilities	HKD 949.9M
Long Term Assets	HKD 788.4M
Long Term Liabilities	HKD 346.2M
Net Cash	HKD -143.4M
Net Cash By Market Cap	HKD -1.11
Net Debt Equity	HKD 0.3
Tangible Book Value	HKD 392.8M
Tangible Book Value Per Share	HKD 2.57

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.07
Inventory Turnover	2.6
Net Working Capital	HKD -168.2M
Quick ratio	1.05
Working Capital	HKD 41.3M

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	94.81
All Time High	134.9
All Time High Change	-42.7%
All Time High Date	2026-02-23
All Time Low	51
All Time Low Change	51.57%
All Time Low Date	2025-11-10
ATR	5.03
Beta1y	1.31
Ch YTD	-5.56
High	77.3
High52	134.9
High52 Date	2026-02-23
High52ch	-42.7%
Low	76.05
Low52	51
Low52 Date	2025-11-10
Low52ch	51.57%
Ma50ch	-18.47%
RSI	39.32
RSI Monthly	0
RSI Weekly	50.28
Sharpe ratio	0.27x
Sortino ratio	0.43
Tr YTD	-5.56
Tr1m	-7.98%
Tr1w	3.83%
Tr3m	-26.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD -372M
Operating margin	-327.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	42,921,641%
Shares Insiders	63.04%
Shares Institutions	0.62%
Shares Out	167,597,800

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	46,820x
Bv Per Share	3.25
Ch1m	-7.98
Ch1w	3.83
Ch3m	-26.73
Ch6m	16.94
Change	-0.19%
Change From Open	0.13
Close	77.45
Days Gap	-0.32
Depreciation Amortization	23,534,494.1
Dollar Volume	2,519,980
Earnings Date	2026-03-31
EBIT	HKD -372M
EBITDA	HKD -349.2M
EPS	HKD -2.59
F Score	0
Fiscal Year End	December
Founded	2,013
Income Tax	HKD 229,239
Is Primary Listing	1
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Ma20	80.81
Ma20ch	-4.34%
Open	77.2
Position In Range	100
Ppne	728,416,601.9
Price Date	2026-05-08
Ptbv Ratio	32.98
Relative Volume	0.7x
Revenue	113,613,475x
Tax By Revenue	0.2x
Tr6m	16.94%
Volume	32,600

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/2630 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns HKG/2630?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.6%

Share of float held by funds and institutions

Insider ownership

+63.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

HKG/2630 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.3

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.27

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2630

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2630 stock rating?

hkg/2630 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2630 analysis?

The full report lives at /stocks/hkg/2630/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2630?

The latest report frames hkg/2630 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2630 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.